Preclinical assessment of the feasibility of applying controlled release oral drug delivery to a lead series of atypical antipsychotics.
Eichenbaum G, Pollock-Dove C, Nguyen J, Li S, Evans J, Borghys H, Kennis L, Dong L, van Osdol W, Dai W, Scicinski J, Chen J, Xu Y, Ashton D, Mackie C, Megens A.
Eichenbaum G, et al. Among authors: megens a.
J Pharm Sci. 2006 Apr;95(4):883-95. doi: 10.1002/jps.20550.
J Pharm Sci. 2006.
PMID: 16489607